Navigation Links
Microbix Announces A New Technology Platform For The SST Project
Date:4/7/2009

    New intellectual property strengthens shareholders' exclusive access to
    the global livestock AI industry

TORONTO, April 7 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) announced today that the Company is proceeding to submit a new patent application, based on discoveries arising from its extensive work on the Semen Sexing Technology (SST) program.

The new technology represents a significant departure from other methods to separate sperm cells by sex, and will potentially provide the Company with a further entree into the global Artificial Insemination (AI) industry. The technology affords shareholders a strong and exclusive intellectual property position and a simplified path through development and commercialization. The Company does not anticipate significant further research-phase investment in SST, and anticipates the ability to focus exclusively on development and commercialization activities with timelines determined accordingly.

"In the high risk world of biotech R&D, this is a success by any standard," said Microbix Chief Executive Officer William J. Gastle. "New intellectual property, in a large market, with a significant competitive advantage, are all criteria to be met when creating shareholder value. That is what we have done here."

The worldwide AI market is over $ 2.5 billion and Microbix estimates that sexed semen will garner a premium price of about 2.5 times the price of unsexed semen product. The Company's previous estimate of royalties of 15% of sales remains unchanged with the new technology. A number of AI companies representing 13% of the market have already agreed to participate in field trials.

The acquisition of the initial protein-based technology and assets from Sequent Biotechnologies in 2005 gave Microbix a significant lead in understanding the structural differences between X and Y chromosome-bearing bovine sperm. In June 2007 the Company reported
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
4. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
5. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
6. Immunotech Laboratories Announces South American Strategy
7. Siemens Healthcare Announces Planned Collaboration with Harris Corporation
8. ChromaDex Announces 2008 Year End Financial Results
9. China Agri-Business Announces 2008 Operating Results
10. Verenium Announces Organizational Changes
11. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... MI (PRWEB) November 22, 2014 ... to simulate the proper management of life-like respiratory ... test lung devices . Grand Rapids-based, Michigan Instruments ... to donate two of the respiratory simulation units ... $15,000 each. Grand Valley and Muskegon Community College ...
(Date:11/21/2014)... 2014 The science of light and ... with more than 200 primary students in a traveling ... University of Otago Physics Department and funded by an ... members of the university’s OSA/SPIE Student Chapter visited six ... giving children from small, rural schools hands-on lessons in ...
(Date:11/21/2014)... The November 2014 issue of BioTechniques ... access journal featuring the following articles:, , ... photoresponsiveness in the retina , DNA from ... using chromogenic substrates in zebrafish , Re-use ... electrophoresis , Nuclear LC3-positive puncta in stressed ...
(Date:11/21/2014)... Nov. 20, 2014 Polaris Group announced ... in its Phase 1 trial of ADI-PEG 20 ... treatment of malignant pleural mesothelioma (MPM) and non-squamous ... clinical trials on ADI-PEG 20, both as monotherapy ... treatment of several other indications, including breast cancer, ...
Breaking Biology Technology:Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
... that helps solve the structure of graphite oxide and ... thick substance called graphene, which has applications in nanoelectronics, ... and cars has been created by researchers at The ... idea of the nanomaterial graphene, imagine a lightweight material ...
... Sept. 25 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,("Dragon Pharma" ... DRP), a,leading international pharmaceutical company, today announced that ... Wong, Chief Financial,Officer will present at 9:30 a.m. ... 2008 at the Chateau Frontenac hotel in Quebec ...
... Expects Revenue of $88 to $90 Million and Net Income of $27 ... ... China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky One ... company producing over-the-counter,drugs in the People,s Republic of China ("PRC"), today announced ...
Cached Biology Technology:New graphene-based material clarifies graphite oxide chemistry 2New graphene-based material clarifies graphite oxide chemistry 3China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3
(Date:11/6/2014)... -- A groundbreaking paper from a team of Florida ... of how plants could adapt to and survive environmental ... published in the latest issue of the journal ... (the complex of DNA and proteins) is organized in ... that some genes are turned on and others are ...
(Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
(Date:11/5/2014)... Janeiro, Brazil -Individuals show great diversity in their ability ... and females greatly differ in their perceptual evaluation of ... smell tests. , Sex differences in olfactory ... and may be connected to one,s perception of smell, ... Thus, women,s olfactory superiority has been suggested to be ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2The female nose always knows: Do women have more olfactory neurons? 2
... University of Missouri leaders celebrated a nanomedicine milestone today ... development company. The new company forms a partnership between ... testing of a potential cancer treatment created at MU. ... suppliers of ibuprofen, formed the new company in partnership ...
... feed itself. And it can make the transition ... The startling assertions, in stark contrast with entrenched, ... studies published today that present a clear prescription for ... economy. The strategy calls on governments to make ...
... Cincinnati, OH, December 2, 2010 -- Managing diabetes in ... exercise. Buying essential medical supplies, such as needles and ... to a new study soon to be published in ... arises from the financial burden of diabetes management increases a ...
Cached Biology News:MU cancer scientists form new company with international pharmaceutical firm 2MU cancer scientists form new company with international pharmaceutical firm 3Africa can feed itself in a generation: Study 2Africa can feed itself in a generation: Study 3Africa can feed itself in a generation: Study 4Africa can feed itself in a generation: Study 5Africa can feed itself in a generation: Study 6Africa can feed itself in a generation: Study 7New study calls for greater awareness of food supply for children with diabetes 2
Protein 3D structure prediction, via threading. Easy to use....
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: